MuCell Extrusion President Mark Lindenfelzer said confusion due to patent and licensing obligations has inhibited the growth of some applications for his company's technology in the marketplace.
"There is an issue in the marketplace of who owns what in terms of technology," Lindenfelzer told PlasticsToday. "There are a number of patents in the marketplace and sometimes the end user is not sure how to handle all the intellectual property. With these two agreements, we hope to help clarify that issue."
The first agreement is for MuCell to exclusively license Dow Chemical thin foamed films patent family, using MuCell foaming technology to create physically foamed films for all film applications.